Navigation Links
European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreich's Ataxia by Santhera
Date:8/19/2007

corporate website, http://www.takeda.com.

Disclaimer/Forward-looking Statements

This news release is not and under no circumstances is to be construed as a solicitation, offer, or recommendation, to buy or sell securities issued by either Santhera or Takeda. Both Santhera and Takeda make no representation (either express or implied) that the information and opinions expressed in this news release are accurate, complete or up to date. Santhera and Takeda disclaim, without limitation, all liability for any loss or damage of any kind, including any direct, indirect or consequential damages, which might be incurred in connection with the information contained in this news release.

Forward-looking statements and other information contained in this release involve risks and uncertainties. Such statements reflect the current views, intentions and estimates of the Santhera and Takeda. They are based on assumptions that may be inaccurate. Results could differ materially from those anticipated. Certain of these forward-looking statements can be identified by the use of forward-looking terminology such as "believe", "expect", "may", "are expected to", "will", "will continue", "should", "would be", "seek" or "anticipate" or by discussions of strategy, plans or intentions. Furthermore, Santhera and Takeda do not assume any obligation to update these forward-looking statements.

For Further Information, Contact

Santhera Pharmaceuticals

Klaus Schollmeier, Chief Executive Officer

phone: +41-(0)61-906-89-52

klaus.schollmeier@santhera.com

Barbara Heller, Chief Financial Officer

phone: +41-(0)61-906-89-54

barbara.heller@santhera.com

Thomas Staffelbach, Public & Investor Relations

phone: +41-(0)61-906-89-47


SOURCE Santhera Pharmaceuticals AG

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5 6

Related biology technology :

1. Mirus granted European patent for gene therapy
2. Info security group announces first Eastern European chapter
3. EMD Biosciences partners with European biotech company
4. Third Wave lands European distribution deal, reports high earnings
5. Biologist who cloned Dolly the sheep believes therapeutic cloning will gain acceptance
6. Biotech crops gaining acceptance, but their full promise has yet to be fulfilled
7. Risks and returns: Building a search engine marketing portfolio
8. The write stuff: marketing with articles
9. StrandVision signs joint marketing agreement with Pacific Signage
10. CPM contributes marketing program to Michigan hospital
11. MyWeather names new president, marketing officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... 2015   GenoSpace , a precision medicine software company that ... broad use of genomic, imaging and other biomedical data in ... Michelle Munson , CEO of Aspera, an IBM Company, to ... http://photos.prnewswire.com/prnh/20150122/170713 "We are pleased to ...
(Date:12/25/2014)... (PRWEB) December 25, 2014 The report ... by Product Type & Provider Type - Global Advancements, ... market with an in-depth analysis and forecasting of revenues. ... spread through 221 pages and in-depth TOC on “Service ...
(Date:12/24/2014)... and NEW YORK , Dec. ... biopharmaceutical company advancing patient care in critical areas, announced the ... common stock, and warrants to purchase up to an aggregate ... $4.00 per share and $.01 per warrant.  The warrants have ...
(Date:12/24/2014)... 2014   BioLife Solutions , Inc. (NASDAQ: BLFS ... grade hypothermic storage and cryopreservation freeze ... and tissues  ("BioLife" or the "Company"), today announced that it ... 4, 2015 (the "Annual Meeting"). Because the expected ...
Breaking Biology Technology:GenoSpace Expands Board with Appointment of Michelle Munson 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 2Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 3Service Quality Management Market worth $2.1 Billion & Telco Customer Experience Management Market worth $2.3 Billion by 2019 – New Report by MarketsandMarkets 4PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 2PlasmaTech Biopharmaceuticals, Inc. Announces Closing of Public Offering 3BioLife Solutions Sets Date for Annual Meeting of Stockholders 2
... Haven, Conn. A study by Yale researchers offers a ... individuals suggesting that it is due less to single ... cause extended segments of the human genome to be missing, ... for identifying genetic differences has traditionally been on point mutations ...
... enzymes from E. coli bacteria, Duke University chemists and ... of features imprinted to create microdevices such as labs-on-a-chip. ... measuring close to 1 nanometer, or billionths of a ... 2007 issue of the Journal of Organic Chemistry. ...
... Coherent, Inc.,(Nasdaq: COHR ) today announced that ... financial statements to correct errors related to,accounting for ... Special Committee was established by,Coherent,s Board of Directors ... historical stock option practices. The Company,requested the independent ...
Cached Biology Technology:Individual differences caused by shuffled chunks of DNA in the human genome 2Individual differences caused by shuffled chunks of DNA in the human genome 3Using catalysts to stamp nanopatterns without ink 2Using catalysts to stamp nanopatterns without ink 3Coherent Announces Restatement Related to Stock-Based Compensation 2Coherent Announces Restatement Related to Stock-Based Compensation 3Coherent Announces Restatement Related to Stock-Based Compensation 4
(Date:12/19/2014)... , Dec. 18, 2014   LaunchKey , the ... the post-password and Internet of Things era, today announced ... The venture round was led by Metamorphic Ventures with ... Venture Partners, VegasTechFund, and others.  LaunchKey has raised $4 ...
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/11/2014)... DUBLIN , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition ... 2015-2019"  report to their offering. One ... technology. With continuous advances in technology, it is important ...
Breaking Biology News(10 mins):LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 2LaunchKey Raises $3 Million in Additional Funding Led by Metamorphic Ventures 3Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... one of the commonest and most serious infections occurring ... cohort and case control studies published in BioMed Central,s ... current smokers with HIV were at double the risk ... people stopped smoking their risk was reduced. The ...
... using any drugs? Starve it to death by ... HDL cholesterol. Northwestern Medicine researchers discovered this ... agent. It appears to the cancerous lymphoma cell like a ... the cell, it actually plugs it up and blocks cholesterol ...
... survivors with plenty of tricks for staying alive. Researchers have ... tumor suppressor BRCA1 can resume one form of DNA repair, ... the January 21 st issue of The ... protein helps to mend double-strand DNA breaks by promoting homologous ...
Cached Biology News:New way to kill lymphoma without chemotherapy 2New way to kill lymphoma without chemotherapy 3Enzyme helps cancer cells avoid genetic instability 2Enzyme helps cancer cells avoid genetic instability 3
Activating Agents, 7-azabenzotriazol-1-yloxy-tris-(pyrrolidino)phosphonium hexafluorophosphate...
Each 72-well MiniTray is low profile, with lid. Conical well shape, 10 l....
The E. coli Expression System with Gateway Technology is designed to create E. coli expression clones containing the T7 promoter. The expression clones are ready for transformation and expression in ...
...
Biology Products: